NOVEL HUMAN ENDOGENOUS RETORVIRAL ERV3 VARIANT AND USES THEREOF FOR DIAGNOSING OVARIAN CANCER

摘要

The present invention relates to polynucleotide and polypeptide sequences of a novel human endogenous retroviral ERV3 variant which is differentially expressed in ovarian cancer cells when compared to normal cells. The present invention more particularly relates to the use of these polynucleotide and polypeptide in the diagnosis, prognosis or treatment of cancer and in the detection of cancer cells.